Cullinan Therapeutics, Inc. CGEM Return on invested capital

Return on invested capital at other companies

Eli LillyLLY

39.7%+10.3pp

Johnson & JohnsonJNJ

19.2%+1.3pp

AmgenAMGN

14.8%+3.6pp

Regeneron PharmaceuticalsREGN

10.3%-1.5pp

Vor BiopharmaVOR

-153.1%-5,641pp

Climb Bio, Inc.CLYM

-39.4%-15.9pp

FAQ

What is Cullinan Therapeutics, Inc.'s return on invested capital?

Cullinan Therapeutics, Inc. (CGEM) reported return on invested capital of -58% in Q4 2025.

How has Cullinan Therapeutics, Inc.'s return on invested capital changed year-over-year?

Cullinan Therapeutics, Inc.'s return on invested capital decreased by 28.0% year-over-year, from -45.4% to -58%.

What is the long-term trend for Cullinan Therapeutics, Inc.'s return on invested capital?

Over 2 years (2023 to 2025), Cullinan Therapeutics, Inc.'s return on invested capital has grown at a 6.2% compound annual growth rate (CAGR), from -51.5% to -58%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.